Company / Depreciation & Amortization
Caribou Biosciences, Inc. Depreciation & Amortization History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.6M
FY2025
5-year range
$751.0K / $3.6M
FY2021-FY2025
Trend
+3.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 4 consecutive years, from $751,000 in FY2021 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 3-year CAGR of +54.7%.
Increased from $2M to $4M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +54.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Caribou Biosciences, Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 3-year CAGR of +54.7%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 3.4% year-over-year.
- Lowest depreciation & amortization in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.6M | +3.4% |
| FY2024 | $3.5M | +117.3% |
| FY2023 | $1.6M | +64.8% |
| FY2022 | $984.0K | +31.0% |
| FY2021 | $751.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026